Published in Biology (Basel) on August 13, 2012
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
Scalable molecular dynamics with NAMD. J Comput Chem (2005) 59.49
Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins (2006) 22.80
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng (1995) 19.22
Selective inhibition of BET bromodomains. Nature (2010) 18.79
HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc (2003) 11.65
Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol (1999) 11.38
Histone acetylation and transcriptional regulatory mechanisms. Genes Dev (1998) 10.16
Structure and ligand of a histone acetyltransferase bromodomain. Nature (1999) 10.08
Intrinsically unstructured proteins. Trends Biochem Sci (2002) 7.96
brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell (1992) 7.63
Histone recognition and large-scale structural analysis of the human bromodomain family. Cell (2012) 5.15
Bromodomain: an acetyl-lysine binding domain. FEBS Lett (2002) 5.03
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A (1989) 5.03
HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets. Proteins (2007) 3.97
RNA recognition by Tat-derived peptides: interaction in the major groove? Cell (1991) 3.83
The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins. Nucleic Acids Res (1992) 3.57
HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J (1999) 3.10
Structural basis for signal-sequence recognition by the translocase motor SecA as determined by NMR. Cell (2007) 3.06
Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem (1999) 2.81
Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res (1989) 2.72
Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat. EMBO J (1988) 2.57
Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J Med Chem (2011) 2.45
High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J Mol Biol (1993) 2.44
Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol Cell (2004) 2.43
Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr Biol (2000) 2.30
Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem (1998) 2.26
Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol Cell (2002) 2.20
Crystal structure of HIV-1 Tat complexed with human P-TEFb. Nature (2010) 2.08
The intrinsic affinity between E2 and the Cys domain of E1 in ubiquitin-like modifications. Mol Cell (2007) 2.05
Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J (2003) 2.02
HIV drug development: the next 25 years. Nat Rev Drug Discov (2007) 2.00
Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science (1990) 1.93
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci U S A (1993) 1.93
Development of antiretroviral drug resistance. N Engl J Med (2011) 1.88
Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc Natl Acad Sci U S A (2007) 1.86
Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300. Structure (2008) 1.86
Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins. J Virol (1990) 1.61
Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology (2000) 1.56
Functional interaction between nucleosome assembly proteins and p300/CREB-binding protein family coactivators. Mol Cell Biol (2000) 1.55
Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J (2002) 1.49
Novel approaches to inhibiting HIV-1 replication. Antiviral Res (2009) 1.48
3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. J Med Chem (2011) 1.48
Molecular basis of human immunodeficiency virus drug resistance: an update. Antiviral Res (2009) 1.46
Structural studies of HIV-1 Tat protein. J Mol Biol (1995) 1.45
Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol Cell (2003) 1.42
SWI/SNF displaces SAGA-acetylated nucleosomes. Eukaryot Cell (2006) 1.36
Targeting HIV: antiretroviral therapy and development of drug resistance. Trends Pharmacol Sci (2002) 1.32
Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails. BMC Struct Biol (2007) 1.32
Solvated docking: introducing water into the modelling of biomolecular complexes. Bioinformatics (2006) 1.29
Periodic boundary conditions in ab initio calculations. Phys Rev B Condens Matter (1995) 1.28
Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery. J Med Chem (2012) 1.28
Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF. EMBO J (2002) 1.27
Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain. J Biol Chem (2010) 1.24
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family. Bioorg Med Chem (2011) 1.23
The role of brahma and related proteins in transcription and development. Curr Opin Genet Dev (1995) 1.21
Study of the Villin headpiece folding dynamics by combining coarse-grained Monte Carlo evolution and all-atom molecular dynamics. Proteins (2005) 1.18
Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. J Am Chem Soc (2005) 1.18
1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. C R Acad Sci III (2000) 1.16
Candidate HIV-1 Tat vaccine development: from basic science to clinical trials. AIDS (2006) 1.12
HIV-1 Tat protein enhances microtubule polymerization. Retrovirology (2005) 1.06
Anti-infectives: clinical progress of HIV-1 integrase inhibitors. Expert Opin Emerg Drugs (2008) 1.04
Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy. Trends Pharmacol Sci (2007) 1.00
Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. Virology (2001) 1.00
Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants. J Biol Chem (2002) 1.00
DNA-binding properties of the recombinant high-mobility-group-like AT-hook-containing region from human BRG1 protein. Biol Chem (2006) 0.99
Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2. FEBS Lett (2010) 0.97
Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein. Biopolymers (2001) 0.97
Transcription of HIV: Tat and cellular chromatin. Adv Pharmacol (2007) 0.96
Tits and bits of HIV Tat protein. Expert Opin Biol Ther (2011) 0.93
Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-associated factor. J Med Chem (2007) 0.92
The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts. Virology (1991) 0.91
The basic RNA-binding domain of HIV-2 Tat contributes to preferential trans-activation of a TAR2-containing LTR. Nucleic Acids Res (1992) 0.91
IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol (1999) 0.87
Progress in the discovery of small-molecule inhibitors of bromodomain--histone interactions. J Biomol Screen (2011) 0.86
Structural analysis of MED-1 reveals unexpected diversity in the mechanism of DNA recognition by GATA-type zinc finger domains. J Biol Chem (2008) 0.84
Comparative analysis of HIV-1 Tat variants. Proteins (2005) 0.82
UV and X-ray structural studies of a 101-residue long Tat protein from a HIV-1 primary isolate and of its mutated, detoxified, vaccine candidate. Proteins (2010) 0.81
Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations. Proteins (2006) 0.80
HIV-1 transcription: activation mediated by acetylation of Tat. Structure (2002) 0.79
Isoform-specific determinants in the HP1 binding to histone 3: insights from molecular simulations. Amino Acids (2009) 0.79
The search for protection against HIV infection. Ann Epidemiol (2009) 0.77
HIV-1 integrase binding to its cellular partners: a perspective from computational biology. Curr Pharm Des (2014) 0.75